Avantor (NYSE:AVTR) Price Target Cut to $25.00

Avantor (NYSE:AVTR) had its price target trimmed by Barclays from $28.00 to $25.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has an overweight rating on the stock.

Several other research analysts have also weighed in on AVTR. Evercore ISI increased their price objective on shares of Avantor from $26.00 to $28.00 and gave the stock an outperform rating in a report on Thursday, April 4th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Avantor from $23.00 to $25.00 and gave the company a hold rating in a report on Thursday, April 18th. Finally, Robert W. Baird cut their price target on shares of Avantor from $27.00 to $26.00 and set an outperform rating on the stock in a report on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus target price of $26.36.

Avantor Trading Down 2.0 %

Shares of AVTR stock opened at $20.77 on Friday. The firm has a market cap of $14.11 billion, a P/E ratio of 53.26, a PEG ratio of 2.15 and a beta of 1.32. Avantor has a 1-year low of $16.63 and a 1-year high of $26.16. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05. The firm’s 50-day simple moving average is $23.73 and its 200-day simple moving average is $23.82.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.02. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The company’s revenue was down 5.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.29 EPS. As a group, equities analysts forecast that Avantor will post 1.01 EPS for the current year.

Institutional Trading of Avantor

Several large investors have recently bought and sold shares of the company. Mesirow Institutional Investment Management Inc. acquired a new stake in shares of Avantor during the fourth quarter worth approximately $2,842,000. Raymond James & Associates grew its position in shares of Avantor by 84.8% during the fourth quarter. Raymond James & Associates now owns 1,165,646 shares of the company’s stock worth $26,612,000 after buying an additional 534,901 shares in the last quarter. Federated Hermes Inc. grew its position in shares of Avantor by 19.9% during the fourth quarter. Federated Hermes Inc. now owns 628,189 shares of the company’s stock worth $14,342,000 after buying an additional 104,296 shares in the last quarter. BNP Paribas Financial Markets grew its position in shares of Avantor by 146.1% during the fourth quarter. BNP Paribas Financial Markets now owns 217,296 shares of the company’s stock worth $4,961,000 after buying an additional 129,010 shares in the last quarter. Finally, DAVENPORT & Co LLC grew its position in shares of Avantor by 17.6% during the fourth quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company’s stock worth $52,430,000 after buying an additional 342,452 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.